Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines

Kelvin A. Moses; Preston C. Sprenkle; Clinton Bahler; Geoffrey Box; Sigrid V. Carlsson; William J. Catalona; Douglas M. Dahl; Marc Dall’Era; John W. Davis; Bettina F. Drake; Jonathan I. Epstein; Ruth B. Etzioni; Thomas A. Farrington; Isla P. Garraway; David Jarrard; Eric Kauffman; Deborah Kaye; Adam S. Kibel; Chad A. LaGrange; Paul Maroni; Lee Ponsky; Brian Reys; Simpa S. Salami; Alejandro Sanchez; Tyler M. Seibert; Terrence M. Shaneyfelt; Marc C. Smaldone; Geoffrey Sonn; Mark D. Tyson; Neha Vapiwala; Robert Wake; Samuel Washington; Alice Yu; Bertram Yuh; Ryan A. Berardi; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2023.0014

Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines

Kelvin A. Moses, Preston C. Sprenkle, Clinton Bahler, Geoffrey Box, Sigrid V. Carlsson, William J. Catalona, Douglas M. Dahl, Marc Dall’Era, John W. Davis, Bettina F. Drake, Jonathan I. Epstein, Ruth B. Etzioni, Thomas A. Farrington, Isla P. Garraway, David Jarrard, Eric Kauffman, Deborah Kaye, Adam S. Kibel, Chad A. LaGrange, Paul MaroniLee Ponsky, Brian Reys, Simpa S. Salami, Alejandro Sanchez, Tyler M. Seibert, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Mark D. Tyson, Neha Vapiwala, Robert Wake, Samuel Washington, Alice Yu, Bertram Yuh, Ryan A. Berardi, Deborah A. Freedman-Cass

Urology

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.

Original language	English (US)
Pages (from-to)	236-246
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2023.0014
State	Published - Mar 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.0014

Cite this

Moses, K. A., Sprenkle, P. C., Bahler, C., Box, G., Carlsson, S. V., Catalona, W. J., Dahl, D. M., Dall’Era, M., Davis, J. W., Drake, B. F., Epstein, J. I., Etzioni, R. B., Farrington, T. A., Garraway, I. P., Jarrard, D., Kauffman, E., Kaye, D., Kibel, A. S., LaGrange, C. A., ... Freedman-Cass, D. A. (2023). Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 21(3), 236-246. https://doi.org/10.6004/jnccn.2023.0014

Moses, KA, Sprenkle, PC, Bahler, C, Box, G, Carlsson, SV, Catalona, WJ, Dahl, DM, Dall’Era, M, Davis, JW, Drake, BF, Epstein, JI, Etzioni, RB, Farrington, TA, Garraway, IP, Jarrard, D, Kauffman, E, Kaye, D, Kibel, AS, LaGrange, CA, Maroni, P, Ponsky, L, Reys, B, Salami, SS, Sanchez, A, Seibert, TM, Shaneyfelt, TM, Smaldone, MC, Sonn, G, Tyson, MD, Vapiwala, N, Wake, R, Washington, S, Yu, A, Yuh, B, Berardi, RA & Freedman-Cass, DA 2023, 'Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 3, pp. 236-246. https://doi.org/10.6004/jnccn.2023.0014

@article{8f86b4eb4d9640f5b252e5a0713983cb,

title = "Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.",

author = "Moses, {Kelvin A.} and Sprenkle, {Preston C.} and Clinton Bahler and Geoffrey Box and Carlsson, {Sigrid V.} and Catalona, {William J.} and Dahl, {Douglas M.} and Marc Dall{\textquoteright}Era and Davis, {John W.} and Drake, {Bettina F.} and Epstein, {Jonathan I.} and Etzioni, {Ruth B.} and Farrington, {Thomas A.} and Garraway, {Isla P.} and David Jarrard and Eric Kauffman and Deborah Kaye and Kibel, {Adam S.} and LaGrange, {Chad A.} and Paul Maroni and Lee Ponsky and Brian Reys and Salami, {Simpa S.} and Alejandro Sanchez and Seibert, {Tyler M.} and Shaneyfelt, {Terrence M.} and Smaldone, {Marc C.} and Geoffrey Sonn and Tyson, {Mark D.} and Neha Vapiwala and Robert Wake and Samuel Washington and Alice Yu and Bertram Yuh and Berardi, {Ryan A.} and Freedman-Cass, {Deborah A.}",

year = "2023",

month = mar,

doi = "10.6004/jnccn.2023.0014",

language = "English (US)",

volume = "21",

pages = "236--246",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines

AU - Moses, Kelvin A.

AU - Sprenkle, Preston C.

AU - Bahler, Clinton

AU - Box, Geoffrey

AU - Carlsson, Sigrid V.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Dall’Era, Marc

AU - Davis, John W.

AU - Drake, Bettina F.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Farrington, Thomas A.

AU - Garraway, Isla P.

AU - Jarrard, David

AU - Kauffman, Eric

AU - Kaye, Deborah

AU - Kibel, Adam S.

AU - LaGrange, Chad A.

AU - Maroni, Paul

AU - Ponsky, Lee

AU - Reys, Brian

AU - Salami, Simpa S.

AU - Sanchez, Alejandro

AU - Seibert, Tyler M.

AU - Shaneyfelt, Terrence M.

AU - Smaldone, Marc C.

AU - Sonn, Geoffrey

AU - Tyson, Mark D.

AU - Vapiwala, Neha

AU - Wake, Robert

AU - Washington, Samuel

AU - Yu, Alice

AU - Yuh, Bertram

AU - Berardi, Ryan A.

AU - Freedman-Cass, Deborah A.

PY - 2023/3

Y1 - 2023/3

N2 - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.

AB - The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.

UR - http://www.scopus.com/inward/record.url?scp=85150005817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150005817&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.0014

DO - 10.6004/jnccn.2023.0014

M3 - Article

C2 - 36898362

AN - SCOPUS:85150005817

SN - 1540-1405

VL - 21

SP - 236

EP - 246

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this